![Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes | Nature Communications Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-12438-5/MediaObjects/41467_2019_12438_Fig1_HTML.png)
Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes | Nature Communications
Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Rece
![The nuclear export protein XPO1 — from biology to targeted therapy | Nature Reviews Clinical Oncology The nuclear export protein XPO1 — from biology to targeted therapy | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-020-00442-4/MediaObjects/41571_2020_442_Fig1_HTML.png)
The nuclear export protein XPO1 — from biology to targeted therapy | Nature Reviews Clinical Oncology
Profiling Novel Sulfonamide Antitumor Agents with Cell-based Phenotypic Screens and Array-based Gene Expression Analysis
![PDF) Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study PDF) Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study](https://i1.rgstatic.net/publication/331576234_Use_of_a_Healthcare_Claims_Database_for_Post-Marketing_Safety_Assessments_of_Eribulin_in_Japan_A_Comparative_Assessment_with_a_Prospective_Post-Marketing_Surveillance_Study/links/5caa3542a6fdcca26d064bad/largepreview.png)
PDF) Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
![Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study | Translational Psychiatry Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-021-01602-5/MediaObjects/41398_2021_1602_Fig1_HTML.png)
Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study | Translational Psychiatry
![An analysis modality for vascular structures combining tissue-clearing technology and topological data analysis | Nature Communications An analysis modality for vascular structures combining tissue-clearing technology and topological data analysis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-32848-2/MediaObjects/41467_2022_32848_Fig1_HTML.png)
An analysis modality for vascular structures combining tissue-clearing technology and topological data analysis | Nature Communications
![Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status | Translational Psychiatry Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-021-01709-9/MediaObjects/41398_2021_1709_Fig1_HTML.png)
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status | Translational Psychiatry
Identification of Combinatorial Drugs that Synergistically Kill both Eribulin-Sensitive and Eribulin-Insensitive Tumor Cells
![Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19 | medRxiv Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19 | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/09/21/2021.09.11.21263419/F4.large.jpg)
Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19 | medRxiv
![PDF) A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors PDF) A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors](https://i1.rgstatic.net/publication/330258285_A_phase_I_study_of_ontuxizumab_a_humanized_monoclonal_antibody_targeting_endosialin_in_Japanese_patients_with_solid_tumors/links/5c360d64458515a4c718e092/largepreview.png)
PDF) A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors
![American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 - Endocrine Practice American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/aa4c9801-55df-40b0-9e07-0a885bc3d04c/gr1.jpg)
American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 - Endocrine Practice
![Frontiers | Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management Frontiers | Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management](https://www.frontiersin.org/files/Articles/592302/fneur-11-592302-HTML/image_m/fneur-11-592302-g001.jpg)